pholcodine has been researched along with rocuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridts, CH; De Clerck, LS; Degerbeck, F; Ebo, DG; Hagberg, H; Stevens, WJ; Venemalm, L | 1 |
| Clarke, RC; Day, C; Goddard, CE; Middleditch, A; Platt, PR; Sadleir, PHM; Weightman, W | 1 |
1 trial(s) available for pholcodine and rocuronium
| Article | Year |
|---|---|
Immunoglobulin E antibodies to rocuronium: a new diagnostic tool.
Topics: Analgesics; Androstanols; Antibodies, Anti-Idiotypic; Antibody Specificity; Codeine; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Morphine; Morpholines; Narcotics; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Reference Values; ROC Curve; Rocuronium; Sensitivity and Specificity; Skin Tests; Succinylcholine | 2007 |
1 other study(ies) available for pholcodine and rocuronium
| Article | Year |
|---|---|
Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Bariatric Surgery; Case-Control Studies; Cefazolin; Codeine; Female; Humans; Incidence; Male; Middle Aged; Morpholines; Neuromuscular Blocking Agents; Obesity; Prospective Studies; Risk Factors; Rocuronium; Young Adult | 2021 |